Skip to main content

New Products

  • MFA gets ready for holidays with new stocking stuffers

    TOLEDO, Ohio — Mark Feldstein and Associates has introduced unique housewares and gifts in time for the holiday season.

    • MFA said its Plant Pal moisture meter now is available in a snowman variety. Each meter features a moisture-sensing probe that measures moisture at a plant's root level to help prevent under- or over-watering. The Plant Pal carries a suggested retail price of $11.95;

  • FDA approves Abbott's Humira for ulcerative colitis

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Abbott for treating ulcerative colitis.

    The agency announced Friday the approval of Humira (adalimumab) for moderate to severe UC. The drug was already approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and juvenile idiopathic arthritis.

    UC is a chronic disease that affects about 620,000 Americans, according to the National Institutes of Health.

  • FDA approves two generic hypertension drugs from Mylan

    PITTSBURGH — Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday, saying that it would launch both drugs immediately.

    Mylan said the Food and Drug Administration approved its irbesartan tablets in the 75 mg, 150 mg and 300 mg strengths and irbesartan and hydrochlorothiazide tablets in the 150 mg/12.5 mg and 300 mg/12.5 mg strengths. The drugs are respectively generic versions of Sanofi's Avapro and Avalide.

  • Energizer introduces safe, flameless candles

    ST. LOUIS — Energizer Household Lighting has introduced an innovative option for those wanting the ambiance of candles without the worry of open flames: Energizer Flameless Wax Candles.

    The Flameless Wax Candles, currently available online and at mass market retailers, feature a realistic flickering LED “flame” and melted edge design at the top of the candle. A three-level timer allows the user to schedule the candle to turn off after four, six or eight hours of use; the candle also can be programmed to turn on at the same time every day.

  • Contigo launches new water bottle for kids

    CHICAGO — Contigo has introduced a new spill-proof water bottle for kids.

    The new, BPA-free Striker water bottle is designed for children ages 3 years and older and features an AutoSpout lid, which includes a kid-friendly push-to-drink button for easy one-handed drinking on the go. The bottle also features a specially designed spill-proof valve — the first AutoSpout water bottle with this feature — which helps kids transition from sippy cups without the mess.

  • Dr. Reddy's launches generic asthma, allergy, bronchospasm drug

    HYDERABAD, India — Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

    The Indian company announced the launch of montelukast sodium oral granules in the 4-mg strength in unit-dose cartons of 30 packets.

    The drug is a version of Merck's Singulair oral granules, which had sales of about $61 million during the 12-month period ended in July, according to IMS Health.

  • Happy Family brings new items to store shelves

    NEW YORK — Happy Family's latest Happy Creamies and Happy Baby Starting Solids pouches are making their way to store shelves.

    Dairy-free and gluten-free, Happy Creamies snacks are made with coconut milk and are available in three flavors for babies and toddlers: Strawberry, raspberry and carrot; carrot, mango and orange; and apple, spinach, pea and kiwi, all containing 50% vegetable ingredients. Happy Creamies are available for a suggested retail price of $3.59 per 1-oz. bag.

  • FDA approves new cancer drug

    SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

    Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.

    Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.

X
This ad will auto-close in 10 seconds